Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
12.82
-0.31 (-2.36%)
Nov 18, 2026, 3:00 PM CST
SHA:605266 Revenue
Jianzhijia Pharmaceutical Chain Group had revenue of 2.10B CNY in the quarter ending September 30, 2026, with 0.18% growth. This brings the company's total for the last twelve months to 8.65B, down -4.90% year-over-year. In the year 2025, Jianzhijia Pharmaceutical Chain Group had annual revenue of 8.92B, down -3.90%. That makes Jianzhijia Pharmaceutical Chain Group the 6,566th largest company in the world by revenue and 913th in China.
Revenue (ttm)
8.65B
Revenue Growth
-4.90%
P/S Ratio
0.22
Revenue / Employee
537.93K
Employees
16,082
Market Cap
1.90B
Revenue by Segment
- Pharmaceutical Retail and Services 8.49B 95.2%
- Convenience Sales Section 410.79M 4.6%
- Others 11.47M 0.1%
- Wholesale Sales 10.29M 0.1%
Fiscal year ended Dec 31, 2025 See the full SHA:605266 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.92B | -361.88M | -3.90% |
| Dec 31, 2024 | 9.28B | 202.15M | 2.23% |
| Dec 31, 2023 | 9.08B | 1.57B | 20.84% |
| Dec 31, 2022 | 7.51B | 2.28B | 43.54% |
| Dec 31, 2021 | 5.23B | 768.60M | 17.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 28.74B |
| Yifeng Pharmacy Chain | 25.38B |
| LBX Pharmacy Chain Joint Stock Company | 22.82B |
| Luyan Pharma | 21.57B |
| Cachet Pharmaceutical | 17.25B |
| Yixintang Pharmaceutical Group | 17.03B |
| ShuYu Civilian Pharmacy Corp. | 10.85B |
| Anhui Huaren Health Pharmaceutical | 5.91B |